Skip to main content
. 2013 Nov;79(21):6655–6664. doi: 10.1128/AEM.01676-13

Table 4.

Sequence and expression characteristics of celB23 fusion and its variants identified from screening of the celBR–aac(3)-IV library

Name 5′ Fusion partner DNA sequence Translated amino acid sequence Max Arr tolerancea aac(3)-IV transcript levelb
celBc ATGCCCAGCATAAGCCCATTTGCCGGCAAGCCGGTCGATCCGGACCGTCTTGTCAATATC MPSISPFAGKPVDPDRLVNI 1.00d ± 0.33 1.00 ± 0.35
D2 ...T.T.CT..T................................................ .ST................. 16.67 ± 1.67 1.29 ± 0.19
D3 ...T.......T.T.A.....T...................................... .S..IT.S............ 16.67 ± 1.67 1.32 ± 0.11
D4 .....A.......T.......A....T..........T.......G.....C........ ....I..T....V..G.L.. 16.67 ± 2.50 0.78 ± 0.24
D5 ...T....................C...........T....C..G............... .S......R...Y.E..... 11.33 ± 0.83 1.13 ± 0.12
D7 ...T...CT.A.........C.......G...............T...T..T........ .STK.....R......FF.. 16.67 ± 1.67 0.70 ± 0.18
D9 ...T...TA....T.............................................. .SI.I............... 16.67 ± 1.33 1.08 ± 0.10
D10 ...A.A.......A...T.A.T...................................... .T..N.YS............ 12.00 ± 0.67 1.44 ± 0.08
D11 ...T.T.......A.......A...............T.......T.....T......C. .S..N..T....V..C.F.T 20.00 ± 2.50 4.74 ± 0.54
D13 ...A.A....A.....A.A..A........................A...A.....A... .T.K.QIT.......H..K. 11.67 ± 1.33 0.80 ± 0.18
D15 ...T.........T......................C....................... .S..I.......H....... 12.50 ± 1.33 0.89 ± 0.07
D17 ...T..........TG...G........................A............... .S...AC.......E..... 9.17 ± 0.83 1.39 ± 0.08
D19 ...T............A...........T.......C...AC..A....C.......... .S...Q...M..HHE.P... 14.17 ± 1.65 1.84 ± 0.13
D20 ...T........................................................ .S.................. 13,33 ± 1.17 2.41 ± 0.13
D21 ...T.........A..T........................................... .S..NL.............. 14.17 ± 1.50 1.45 ± 0.10
a

Max Arr tolerance is the maximum apramycin concentration tolerated by DH5α host cells (induction with 0.05 mM m-toluate). All values are relative to the tolerance level of the wild-type strain DH5α(pARcelB23), which is arbitrarily set to 1 and corresponds to 0.06 g/liter.

b

All values are relative to the celB23aac(3)-IV transcript level, which is arbitrarily set to 1.

c

Only the region where random mutations had occurred is shown (first 60 nucleotides/first 20 amino acids).

d

The apramycin resistance level of the wild-type strain DH5α(pARcelB23) (0.06 ± 0.02 g/liter) slightly differs from the level given in Fig. 4 (0.05 ± 0.02 g/liter; 0.05 mM m-toluate induction). This is because the experiments represent the average of different biological replicates (each experiment is performed as two individual biological replicates with a minimum of 4 technical replicates).